New advice for the NHS recommends that people coming off the obesity jabs like Wegovy and Mounjaro should have check-ups for at least a year to make sure they don’t pile weight back on.
Research shows that many people regain weight after stopping treatment if they don’t get the right help. This can negatively affect both their physical and mental health says the health assessment body NICE.
Successful weight management doesn’t end when medication stops or when someone completes a behavioural programme.
“We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they’ve made.
“This new standard makes sure services provide that vital continuity of care, and it supports the NHS 10 Year Plan to shift from a ‘sickness service’ to a genuine health service focused on prevention.”
says Professor Jonathan Benger, deputy chief executive and chief medical officer at NICE
In England, 29% of adults are living with obesity, and 64% are classified as overweight or obese. Obesity is known to increase the risk of a number of serious conditions including type 2 diabetes, heart disease, some cancers and musculoskeletal problems – with rising prevalence placing growing pressure on the NHS and the wider economy.
Estimates suggest obesity costs the NHS £11.4 billion a year, with a wider economic impact of £74.3 billion due to lost productivity, unemployment and increased demand for social care.
Healthcare providers and commissioners are expected to begin rolling out the standard immediately. Resource impact guidance is available to help services embed the changes locally.
